photo of

Details

Role Theme Director - Stem Cell Medicine
Research area Stem Cell Medicine

Contact

Available for student supervision
Professor Porrello is the Theme Director of Stem Cell Medicine and Head of the Heart Regeneration group at the Murdoch Children’s Research Institute (MCRI). He also directs the Melbourne Node of the recently established Novo Nordisk Foundation Centre for Stem Cell Medicine (reNEW) and he is the founding Co-Director of the Melbourne Centre for Cardiovascular Genomics and Regenerative Medicine (CardioRegen). Professor Porrello’s research focuses on the development of regenerative therapies for children and adults with heart failure. Throughout his career, he has made important contributions to our understanding of mammalian heart regeneration and has pioneered the development of human organoids for drug discovery. Professor Porrello is a co-founder of Dynomics, a biotechnology company focused on the development of new heart failure treatments using organoid technologies.

After completing his PhD in Physiology at the University of Melbourne, Professor Porrello was awarded an NHMRC/NHF C.J. Martin Fellowship to undertake postdoctoral training in Prof Eric Olson's laboratory at UT Southwestern Medical Center in Dallas, USA. Upon returning to Australia in 2012, Professor Porrello established the Cardiac Regeneration Laboratory at The University of Queensland, which he co-headed together with Dr James Hudson from 2013-2017.
Professor Porrello is the Theme Director of Stem Cell Medicine and Head of the Heart Regeneration group at the Murdoch Children’s Research Institute (MCRI). He also directs the Melbourne Node of the recently established Novo Nordisk Foundation...
Professor Porrello is the Theme Director of Stem Cell Medicine and Head of the Heart Regeneration group at the Murdoch Children’s Research Institute (MCRI). He also directs the Melbourne Node of the recently established Novo Nordisk Foundation Centre for Stem Cell Medicine (reNEW) and he is the founding Co-Director of the Melbourne Centre for Cardiovascular Genomics and Regenerative Medicine (CardioRegen). Professor Porrello’s research focuses on the development of regenerative therapies for children and adults with heart failure. Throughout his career, he has made important contributions to our understanding of mammalian heart regeneration and has pioneered the development of human organoids for drug discovery. Professor Porrello is a co-founder of Dynomics, a biotechnology company focused on the development of new heart failure treatments using organoid technologies.

After completing his PhD in Physiology at the University of Melbourne, Professor Porrello was awarded an NHMRC/NHF C.J. Martin Fellowship to undertake postdoctoral training in Prof Eric Olson's laboratory at UT Southwestern Medical Center in Dallas, USA. Upon returning to Australia in 2012, Professor Porrello established the Cardiac Regeneration Laboratory at The University of Queensland, which he co-headed together with Dr James Hudson from 2013-2017.

Top Publications

  • Lock, MC, Tellam, RL, Darby, JRT, Soo, JY, Brooks, DA, Macgowan, CK, Selvanayagam, JB, Porrello, ER, Seed, M, Keller-Wood, M, et al. Differential gene responses 3 days following infarction in the fetal and adolescent sheep heart.. Physiol Genomics 52(3) : 143 -159 2020
    view publication
  • McOwan, TN, Craig, LA, Tripdayonis, A, Karavendzas, K, Cheung, MM, Porrello, ER, Conyers, R, Elliott, DA. Evaluating anthracycline cardiotoxicity associated single nucleotide polymorphisms in a paediatric cohort with early onset cardiomyopathy.. Cardiooncology 6: 5 2020
    view publication
  • Mills, R, Humphrey, S, Fortuna, PRJ, Lor, M, Foster, S, Quaife-Ryan, G, Johnston, R, Dumenil, T, Bishop, C, Ruraraju, R, et al. Bromodomain and Extraterminal Inhibition Blocks Inflammation-Induced Cardiac Dysfunction and SARS-CoV-2 Infection (Pre-Clinical). 2020
    view publication
  • Mills, RJ, Humphrey, S, Fortuna, PR, Quaife-Ryan, G, Lor, M, Ruraraju, R, Rawle, D, Le, T, Zhao, W, Lee, L, et al. Bromodomain Inhibition Blocks Inflammation-Induced Cardiac Dysfunction and SARS-CoV2 Infection. 2020
    view publication
  • Arasaratnam, D, Bell, KM, Sim, CB, Koutsis, K, Anderson, DJ, Qian, EL, Stanley, EG, Elefanty, AG, Cheung, MM, Oshlack, A, et al. Publisher Correction: The role of cardiac transcription factor NKX2-5 in regulating the human cardiac miRNAome.. Sci Rep 9(1) : 20269 2019
    view publication

Page 11 of 27